[1]
Remya, S., Sudha, M.J., Nair, B.R. and Jayakumar, K.L. 2017. A prospective comparative study of efficacy of lenalidomide plus dexamethasone combination therapy versus VAD (vincristine, doxorubicin and dexamethasone) regimen in the treatment of multiple myeloma. International Journal of Basic & Clinical Pharmacology. 6, 3 (Feb. 2017), 636–642. DOI:https://doi.org/10.18203/2319-2003.ijbcp20170828.